
Pipraj 4000mg/500mg Injection
Marketer
Auroswift Pharma
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Pipraj 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by the treating physician based on individual health conditions. Strict adherence to prescribed usage is crucial. Potential side effects may include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney or liver impairments to your doctor, who may adjust the medication or prescribe an alternative. While generally safe under medical guidance, its use during pregnancy or breastfeeding requires physician supervision.
Uses of Pipraj 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Pipraj 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pipraj 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Pipraj 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Pipraj 4000mg/500mg Injection works:
Pipraj Injection (4000mg/500mg) combines piperacillin, a bacterial growth inhibitor, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concomitant use of Pipraj 4000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Pipraj, 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models have revealed minimal to no negative impacts on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Pipraj 4000mg/500mg Injection poses no known breastfeeding safety concerns. Research in humans indicates minimal to negligible transfer of the drug into breast milk, presenting no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pipraj 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, administration of Pipraj 4000mg/500mg Injection requires careful monitoring. Dosage modification of Pipraj 4000mg/500mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pipraj 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Pipraj 4000mg/500mg Injection :
Should you forget a scheduled Pipraj 4000mg/500mg Injection, seek medical advice.
Facts to Know About Pipraj 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
